Contineum Therapeutics (CTNM) Interest Coverage Ratio (2023)

Contineum Therapeutics' Interest Coverage Ratio history runs 4 years deep, the most recent figure standing at 0.42 for Q2 2026.

• In Q2 2026, Interest Coverage Ratio rose 83.91% year-over-year to 0.42; the TTM figure through Jun 2026 stood at 1.59 (up 83.39% YoY), while the FY2025 annual figure was 1.42, up 0.96% from the prior year.
• Interest Coverage Ratio for Q2 2026 stood at 0.42, up from 0.7 in the prior quarter.
• The five-year high for Interest Coverage Ratio was 335.66 in Q2 2023, with the low at 135.29 in Q4 2024.
• The 4-year median for Interest Coverage Ratio is 0.75 (2025), against an average of 25.84.
• The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio surged 99.34% in 2024, then slumped 578.07% in 2025.
• Contineum Therapeutics' Interest Coverage Ratio stood at 166.83 in 2023, then tumbled by 181.1% to 135.29 in 2024, then soared by 85.17% to 20.06 in 2025, then soared by 97.92% to 0.42 in 2026.
• Business Quant data shows CTNM's Interest Coverage Ratio at 0.42 in Q2 2026, 0.7 in Q1 2026, and 20.06 in Q4 2025.